The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction
Open accessAbstract
Background Individuals with nonalcoholic fatty liver disease (NAFLD) have excess intrahepatic triglycerides. This is due, in part, to increased hepatic synthesis of fat from carbohydrates via lipogenesis. Although weight loss is currently recommended to treat NAFLD, little attention has been given to dietary carbohydrate restriction.Objective The aim of this study was to determine the effectiveness of 2 wk of dietary carbohydrate and calorie restriction at reducing hepatic triglycerides in subjects with NAFLD.Design Eighteen NAFLD subjects (n = 5 men and 13 women) with a mean (±SD) age of 45 ± 12 y and a body mass index (in kg/m(2)) of 35 ± 7 consumed a carbohydrate-restricted (<20 g/d) or calorie-restricted (1200-1500 kcal/d) diet for 2 wk. Hepatic triglycerides were measured before and after intervention by magnetic resonance spectroscopy.Results Mean (±SD) weight loss was similar between the groups (-4.0 ± 1.5 kg in the calorie-restricted group and -4.6 ± 1.5 kg in the carbohydrate-restricted group; P = 0.363). Liver triglycerides decreased significantly with weight loss (P < 0.001) but decreased significantly more (P = 0.008) in carbohydrate-restricted subjects (-55 ± 14%) than in calorie-restricted subjects (-28 ± 23%). Dietary fat (r = 0.643, P = 0.004), carbohydrate (r = -0.606, P = 0.008), posttreatment plasma ketones (r = 0.755, P = 0.006), and respiratory quotient (r = -0.797, P < 0.001) were related to a reduction in liver triglycerides. Plasma aspartate, but not alanine, aminotransferase decreased significantly with weight loss (P < 0.001).Conclusions Two weeks of dietary intervention (≈4.3% weight loss) reduced hepatic triglycerides by ≈42% in subjects with NAFLD; however, reductions were significantly greater with dietary carbohydrate restriction than with calorie restriction. This may have been due, in part, to enhanced hepatic and whole-body oxidation. This trial was registered at clinicaltrials.gov as NCT01262326.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such rapidly digested, low-fiber carbohydrates drive many obesogenic pathways. 45, 46, 48-50”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [48]
Citations
Cites
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citationDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo
Szczepaniak, L. S., Babcock, E. E., Schick, F., Dobbins, R. L., Garg, A., Burns, D. K., McGarry, J. D., & Stein, D. T. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e977 · Cited by 688
AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Sheth, S. G., Flamm, S. L., Gordon, F. D., & Chopra, S. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.044_c.x · Cited by 583
Cited by
Sorted by citations
Nonalcoholic Fatty Liver Disease
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,320
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,682
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674
Mardinoğlu, A., Wu, H., Björnson, E., Zhang, C., Hakkarainen, A., Räsänen, S., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 465
Ketone body metabolism and cardiovascular disease
Cotter, D. G., Schugar, R. C., & Crawford, P. A. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00646.2012 · Cited by 459
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 412
Management of NAFLD: a stage-based approach
Rinella, M. E., & Sanyal, A. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.3 · Cited by 393
ESPEN practical guideline: clinical nutrition in liver disease
Bischoff, S. C., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Plauth, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.001 · Cited by 383
Role of Mitochondria in Nonalcoholic Fatty Liver Disease
Nassir, F., & Ibdah, J. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058713 · Cited by 369
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Lonardo, A., Nascimbeni, F., Targher, G., Bernardi, M., Bonino, F., Bugianesi, E., Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.147 · Cited by 313
Sullivan, S. A., Kirk, E. P., Mittendorfer, B., Patterson, B. W., & Klein, S. (2011) · Hepatology · doi:10.1002/hep.25548 · Cited by 313
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294
Evolution of NAFLD and Its Management
Mundi, M. S., Velapati, S. R., Patel, J. R., Kellogg, T. A., Dayyeh, B. K. A., & Hurt, R. T. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10449 · Cited by 299
Caprio, M., Infante, M., Moriconi, E., Armani, A., Fabbri, A., Mantovani, G., Mariani, S., Lubrano, C., Poggiogalle, E., Migliaccio, S., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01061-2 · Cited by 283
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Kang, S. H., Lee, H. W., Yoo, J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Ahn, S. B., Ahn, S. B., Kim, H., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0178 · Cited by 276
Katsagoni, C. N., Georgoulis, M., Papatheodoridis, G. V., Panagiotakos, D. B., & Kontogianni, M. D. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.006 · Cited by 270
Current efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z. D., & Sanyal, A. J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 268
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Aron‐Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.049 · Cited by 252
Nutritional ketosis for weight management and reversal of metabolic syndrome
Gershuni, V. M., Yan, S. L., & Medici, V. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0235-0 · Cited by 239
Gepner, Y., Shelef, I., Komy, O., Cohen, N., Schwarzfuchs, D., Bril, N., Rein, M., Serfaty, D., Kenigsbuch, S., Zelicha, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.013 · Cited by 236
Holmer, M., Lindqvist, C., Petersson, S., Moshtaghi-Svensson, J., Tillander, V., Brismar, T. B., Hagström, H., & Stål, P. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100256 · Cited by 224
Watanabe, M., Tozzi, R., Risi, R., Tuccinardi, D., Mariani, S., Basciani, S., Spera, G., Lubrano, C., & Gnessi, L. (2020) · Obesity Reviews · doi:10.1111/obr.13024 · Cited by 220
Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies
Kosinski, C., & Jornayvaz, F. R. (2017) · Nutrients · doi:10.3390/nu9050517 · Cited by 225
Haigh, L., Kirk, C., El Gendy, K., Gallacher, J., Errington, L., Mathers, J. C., & Anstee, Q. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.037 · Cited by 209
Nonalcoholic Fatty Liver Disease
Wang, X., & Malhi, H. (2018) · Annals of Internal Medicine · doi:10.7326/aitc201811060 · Cited by 212
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Xiao, Y.-L., Gong, Y., Qi, Y.-J., Shao, Z., & Jiang, Y.-Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01771-x · Cited by 218
Non-alcoholic fatty liver disease: What the clinician needs to know
Machado, M. V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12956 · Cited by 215
Protein leverage and energy intake
Gosby, A. K., Conigrave, A. D., Raubenheimer, D., & Simpson, S. J. (2014) · Obesity Reviews · doi:10.1111/obr.12131 · Cited by 196
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Fletcher, J. A., Deja, S., Satapati, S., Fu, X., Burgess, S. C., & Browning, J. D. (2019) · JCI Insight · doi:10.1172/jci.insight.127737 · Cited by 200
Self-citationInterorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jeleník, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 194
Diet and exercise in NAFLD/NASH: Beyond the obvious
Semmler, G., Datz, C., Reiberger, T., & Trauner, M. (2021) · Liver International · doi:10.1111/liv.15024 · Cited by 187
Evidence that supports the prescription of low-carbohydrate high-fat diets: A narrative review
Noakes, T. D., & Windt, J. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096491 · Cited by 178
Patel, N. S., Doycheva, I., Peterson, M. R., Hooker, J., Kisselva, T., Schnabl, B., Seki, E., Sirlin, C. B., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.039 · Cited by 173
Ma, W., Wu, J. H. Y., Wang, Q., Lemaître, R. N., Mukamal, K. J., Djoussé, L., King, I. B., Song, X., Biggs, M. L., Delaney, J. A., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092601 · Cited by 166
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
McCarthy, E. M., & Rinella, M. E. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jada.2011.10.007 · Cited by 166
Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y., & Fu, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30121 · Cited by 162
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
Yki‐Järvinen, H. (2015) · Nutrients · doi:10.3390/nu7115454 · Cited by 155
Dietary strategies to reduce metabolic syndrome
Andersen, C. J., & Fernández, M. L. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9251-y · Cited by 149
Zelber‐Sagi, S., Godos, J., & Salomone, F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16638830 · Cited by 141
Role of diet and lifestyle changes in nonalcoholic fatty liver disease.
Nseir, W., Hellou, E., & Assy, N. (2014) · PubMed Central · doi:10.3748/wjg.v20.i28.9338 · Cited by 147
Mozaffarian, D. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz053 · Cited by 139
Cuthbertson, D. J., Shojaee-Moradie, F., Sprung, V. S., Jones, H., Pugh, C. J. A., Richardson, P., Kemp, G. J., Barrett, M., Jackson, N. C., Thomas, E. L., et al. (2016) · Clinical Science · doi:10.1042/cs20150447 · Cited by 138
β-hydroxybutyrate and its metabolic effects on age-associated pathology
Han, Y., Ramprasath, T., & Zou, M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0415-z · Cited by 140
The Ketogenic Diet: Evidence for Optimism but High-Quality Research Needed
Ludwig, D. S. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz308 · Cited by 133
Influence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism
Parry, S. A., & Hodson, L. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000524 · Cited by 141
The Influence of Dietary Fat on Liver Fat Accumulation
Green, C., & Hodson, L. (2014) · Nutrients · doi:10.3390/nu6115018 · Cited by 141
Kenneally, S., Sier, J. H., & Moore, J. B. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000139 · Cited by 135
A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
Moore, M. P., Cunningham, R. P., Dashek, R. J., Mucinski, J. M., & Rector, R. S. (2020) · Obesity · doi:10.1002/oby.22964 · Cited by 131
Schattenberg, J. M., & Schuppan, D. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834c7cfc · Cited by 120
Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry
Longo, R., Peri, C., Cricrì, D., Coppi, L., Caruso, D., Mitro, N., Fabiani, E. D., & Crestani, M. (2019) · Nutrients · doi:10.3390/nu11102497 · Cited by 123
Croci, I., Byrne, N. M., Choquette, S., Hills, A. P., Chachay, V., Clouston, A. D., O'Moore‐Sullivan, T. M., Macdonald, G. A., Prins, J. B., & Hickman, I. J. (2012) · Gut · doi:10.1136/gutjnl-2012-302789 · Cited by 119
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
(2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.4.325 · Cited by 115
Eslamparast, T., Tandon, P., & Raman, M. (2017) · Nutrients · doi:10.3390/nu9080800 · Cited by 109
Sargeant, J. A., Gray, L. J., Bodicoat, D. H., Willis, S. A., Stensel, D. J., Nimmo, M. A., Aithal, G. P., & King, J. A. (2018) · Obesity Reviews · doi:10.1111/obr.12719 · Cited by 105
Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
Schugar, R. C., & Crawford, P. A. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283547157 · Cited by 107
The influence of dietary fatty acids on liver fat content and metabolism
Hodson, L., Rosqvist, F., & Parry, S. A. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000569 · Cited by 98
Insulin resistance and bariatric surgery
Rao, R. S., Yanagisawa, R. T., & Kini, S. U. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00955.x · Cited by 91
Mediterranean diet and non-alcoholic fatty liver disease: New therapeutic option around the corner?
Sofi, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7339 · Cited by 91
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
Mooli, R. G. R., & Ramakrishnan, S. K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.946474 · Cited by 92
Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational Study
Drinda, S., Grundler, F., Neumann, T. E., Lehmann, T., Steckhan, N., Michalsen, A., & de Toledo, F. W. (2019) · Nutrients · doi:10.3390/nu11112601 · Cited by 87
Hydes, T., Ravi, S., Loomba, R. S., & Gray, M. E. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0067 · Cited by 90
Paoli, A., Bianco, A., Moro, T., Mota, J. F., & Coelho‐Ravagnani, C. D. F. (2023) · Nutrients · doi:10.3390/nu15143120 · Cited by 91
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 83
Utzschneider, K. M., Bayer-Carter, J. L., Arbuckle, M. D., Tidwell, J. M., Richards, T. L., & Craft, S. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002966 · Cited by 81
Ahn, J., Jun, D. W., Lee, H. Y., & Moon, J. H. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.022 · Cited by 84
Ketogenic Diets and Exercise Performance
Harvey, K. L., Holcomb, L. E., & Kolwicz, S. C. (2019) · Nutrients · doi:10.3390/nu11102296 · Cited by 92
Linden, M. A., Fletcher, J. A., Morris, E. M., Meers, G. M.-E., Kearney, M. L., Crissey, J. M., Laughlin, M. H., Booth, F. W., Sowers, J. R., Ibdah, J. A., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2013 · Cited by 83
Smith, J. D., Hou, T., Hu, F. B., Rimm, E. B., Spiegelman, D. L., Willett, W. C., & Mozaffarian, D. (2015) · Journal of Nutrition · doi:10.3945/jn.115.214171 · Cited by 78
Goss, A. M., Dowla, S. A., Pendergrass, M., Ashraf, A. P., Bolding, M., Morrison, S. A., Amerson, A., Soleymani, T., & Gower, B. A. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12630 · Cited by 78
Kim, N. H., Kim, J. H., Kim, Y. J., Yoo, H. J., Kim, H. Y., Seo, J. A., Kim, N. H., Choi, K. M., Baik, S. H., Choi, D. S., et al. (2014) · Liver International · doi:10.1111/liv.12454 · Cited by 77
Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies
Tomic, D., Kemp, W. W., & Roberts, S. K. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001235 · Cited by 76
Paoli, A., & Cerullo, G. (2023) · Antioxidants · doi:10.3390/antiox12051065 · Cited by 79
Faria, S. L., Faria, O. P., Cardeal, M. D. A., & Ito, M. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.007 · Cited by 75
Moon, J. S., Hong, J. H., Jung, Y. J., Ferrannini, E., Nauck, M. A., & Lim, S. K. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.03.005 · Cited by 76
Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD
Worm, N. (2020) · Nutrients · doi:10.3390/nu12051316 · Cited by 78
Lambert, J. E., Parnell, J. A., Eksteen, B., Raman, M., Bomhof, M. R., Rioux, K. P., Madsen, K. L., & Reimer, R. A. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0400-5 · Cited by 73
Brouwers, B., Schrauwen‐Hinderling, V. B., Jeleník, T., Gemmink, A., Sparks, L. M., Havekes, B., Bruls, Y. M. H., Dahlmans, D., Roden, M., Hesselink, M. K. C., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2017 · Cited by 68
Pinto, A. M., Bordoli, C., Buckner, L., Kim, C., Kaplan, P. C., del Arenal, I. M., Jeffcock, E. J., & Hall, W. L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.014 · Cited by 71
von Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 70
Effects of Diet on High-Density Lipoprotein Cholesterol
Siri‐Tarino, P. W. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0207-y · Cited by 70
Haghighatdoost, F., Salehi‐Abargouei, A., Surkan, P. J., & Azadbakht, L. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.187269 · Cited by 66
Saeed, N., Nadeau, B., Shannon, C., & Tincopa, M. (2019) · Nutrients · doi:10.3390/nu11123064 · Cited by 65
Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review
Arab, J. P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12182 · Cited by 66
Foods, obesity, and diabetes—are all calories created equal?
Mozaffarian, D. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw024 · Cited by 70
Ross, A. B., Godin, J., Minehira, K., & Kirwan, J. P. (2013) · International Journal of Endocrinology · doi:10.1155/2013/585876 · Cited by 64
Consumption Of Specific Foods And Beverages And Excess Weight Gain Among Children And Adolescents
Dong, D., Bilger, M., van Dam, R. M., & Finkelstein, E. A. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0434 · Cited by 64
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 69
Parra-Vargas, M., Rodriguez‐Echevarría, R., & Jiménez‐Chillarón, J. C. (2020) · Nutrients · doi:10.3390/nu12123860 · Cited by 64
Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome
Rahimi, R. S., & Landaverde, C. E. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533612470464 · Cited by 60
Long, F., Bhatti, M. R., Kellenberger, A., Sun, W., Modica, S., Höring, M., Liebisch, G., Krieger, J.-P., Wolfrum, C., & Challa, T. D. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101675 · Cited by 64
Lipidomes in health and disease: Analytical strategies and considerations
Wei, F., Lamichhane, S., Orešič, M., & Hyötyläinen, T. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115664 · Cited by 61
Agius, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.019 · Cited by 58
High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
Chiara, F. D., Checcllo, C. U., & Ramón‐Azcón, J. (2019) · Nutrients · doi:10.3390/nu11122985 · Cited by 58
Guess, N. D. (2018) · Nutrients · doi:10.3390/nu10091245 · Cited by 64
Dietary Patterns in Secondary Prevention of Heart Failure: A Systematic Review
Padilha, G. D. R., d’Almeida, K. S. M., Spillere, S. R., & Souza, G. C. (2018) · Nutrients · doi:10.3390/nu10070828 · Cited by 60
Astrup, A. V., Bradley, B. H. R., Brenna, J. T., Delplanque, B., Ferry, M., & Torres‐Gonzalez, M. (2016) · Nutrients · doi:10.3390/nu8080463 · Cited by 55
Crabtree, C. D., Kackley, M. L., Buga, A., Fell, B., LaFountain, R. A., Hyde, P. N., Sapper, T. N., Kraemer, W. J., SCANDLING, D. M., Simonetti, O. P., et al. (2021) · Nutrients · doi:10.3390/nu13030966 · Cited by 55
Metadata
- Authors
- Browning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 93
- Issue
- 5
- Pages
- 1048-1052
- ISSN
- 0002-9165 (ISSN-L)
- PMC
- PMC3076656
- OpenAlex
- W2129727129
- Cited by
- 328
- References
- 31
- Citations by year
- 2026: 11 · 2025: 26 · 2024: 24 · 2023: 23 · 2022: 40 · 2021: 20 · 2020: 21 · 2019: 24 · 2018: 23 · 2017: 22 · 2016: 21 · 2015: 13 · 2014: 22 · 2013: 17 · 2012: 12
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (PL1DK081182, DK082872, U01DK082872, PL1DK081183, RL1DK081187, K23DK074396, R01DK087977, R01DK078184)
- National Institute of Dental and Craniofacial Research (UL1DE019584)
- National Center for Research Resources (P41RR002584, UL1RR024982, RR‐02584)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- non-alcoholic fatty liver disease, hepatic triglycerides, carbohydrate restriction, caloric restriction, weight loss, lipogenesis, ketones, respiratory quotient, transaminases, short-term dietary intervention, dietary fat intake, obesity, liver fat reduction, hepatic steatosis
- MeSH terms
- Adult, Diet, Reducing, Fatty Liver, Female, Humans, Ketones, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Oxygen Consumption, Triglycerides, Weight Loss, Body Mass Index, Diet, Carbohydrate-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review